Aktie A042520 HANSBIOMED CORPORATION
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen HansBiomed Corporation

Aktien

A042520

KR7042520007

A042520

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 14.05.2024 		% 5 Tage % 1. Jan.
13 490 KRW +7,06 % Intraday Chart für HansBiomed Corporation +3,13 % -8,11 %
14.02. HansBiomed Corporation meldet Ergebnis für das erste Quartal bis zum 31. Dezember 2023 CI
2023 HansBiomed Corporation meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 31. März 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
HansBiomed Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023
HansBiomed Corporation(KOSDAQ:A042520) added to S&P Global BMI Index
HansBiomed Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on June 23, 2022.
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on June 23, 2022.
HansBiomed Corporation's Equity Buyback announced on June 23, 2022, has expired with 202,283 shares, representing 2.08% for KRW 1,986.65 million.
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on June 23, 2022.
HansBiomed Corporation(KOSDAQ:A042520) dropped from S&P Global BMI Index
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on January 17, 2022.
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on January 17, 2022.
HansBiomed Corporation's Equity Buyback announced on January 17, 2022, has expired with 246,000 shares, representing 2.46% for KRW 2,962.2 million.
HansBiomed Corporation announces an Equity Buyback for KRW 2,000 million worth of its shares.
HansBiomed Corporation authorizes a Buyback Plan.
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on January 17, 2022.
HansBiomed Corporation announces an Equity Buyback for KRW 3,000 million worth of its shares.
HansBiomed Corporation authorizes a Buyback Plan.
HansBiomed Corporation Auditor Raises 'Going Concern' Doubt
HansBiomed Corporation announced that it has received KRW 15 billion in funding from Noh & Partners Corporation
Rebirth Biotechnology Co., Ltd announced that it has received CNY 20 million in funding from HansBiomed Corporation
Rebirth Biotechnology Co., Ltd announced that it expects to receive CNY 20 million in funding from HansBiomed Corporation
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A042520 Aktie
  4. Nachrichten HansBiomed Corporation
  5. Andere Sprachen